Figure 1.

Proportion of subjects achieving targets defined by Canadian guidelines*. Error bars = standard error. *Canadian Cardiovascular Society/Canadian Dyslipidemia guidelines (2012) [4]. † Triple combination includes LDL-C ≤2.0 mmol/L, non-HDL-C ≤2.6 mmol/L, and Apo B ≤0.8 g/L. A, atorvastatin (10, 20 or 40 mg); Apo, apolipoprotein; AVD, atherosclerotic vascular disease; E, ezetimibe 10 mg; LDL-C, low-density lipoprotein cholesterol; non-HDL-C, non-high-density lipoprotein cholesterol.

Constance et al. Lipids in Health and Disease 2014 13:13   doi:10.1186/1476-511X-13-13
Download authors' original image